A rare disease patient should not have to choose between joining a

From Tuesday through Thursday, our CEO, Geert Briers, will be attending the

Next week, Amsterdam becomes the global hub for rare disease innovation at

Starting January 1, 2026, the FAMHP will implement accelerated timelines for the

We’re proud to announce that our CEO, Geert Briers, will represent Deltaclinical at two major

In September 2024, the FDA released a document regarding the conduct of

Deltaclinical is participating Bio Japan from 9 – 11 OCT.

Would you like to learn more about our services? Visit us at booth C-24. We are happy to welcome you!

But first, our CEO Geert Briers will attend the EU-Japan center conference in Osaka from 7 – 8 OCT.